BSEResult2d ago · 23 Oct 2026, 04:27 pm
Outcome of the Board Meeting held on Friday, October 23, 2026
Jupiter Life Line Hospitals Ltd · 543980
✦ AI SummaryResults
Jupiter Life Line Hospitals Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, along with the incorporation of a wholly owned subsidiary and the acquisition of land for ₹150 Crores.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jupiter Life Line Hospitals Ltd - 543980 - Unaudited Financial Results (Standalone & Consolidated) For Quarter And Half Year Ended September 30, 2026
Attachments (1)
📄pdf
Download →
60414cad-2faf-4885-b242-76a98f71d345.pdf
View document text
October 23, 2026
To, To,
National Stock Exchange of India Ltd. BSE Limited
Exchange Plaza, BKC P.J. Towers,
Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort
Bandra (East), Mumbai-400 051 Mumbai 400 001
Symbol: JLHL Code: 543980
Subject: Outcome of the Board Meeting held on Friday, October 23, 2026
Dear Sir/Madam,
In furtherance to our intimation dated October 08, 2026, this is to inform you that pursuant to Regulations
30, 33, and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“Listing Regulations”), the Board of Directors of the Company at its Meeting held today, i.e., October 23,
2026, has inter-alia: -
a) Considered and approved the Unaudited Financial Results (both standalone and consolidated basis) for
the quarter and half year ended on September 30, 2026 along with the Limited Review Report. A copy of
the said Results is enclosed herewith as Annexure – I.
b) Considered and approved the incorporation of a wholly owned subsidiary of the Company. The details as
required in terms of SEBI Listing Regulations and SEBI Master Circular dated January 30, 2026 are
enclosed herewith as Annexure – II.
c) With reference to our announcement dated February 22, 2026 regarding acquisition of land on lease at
South Pune, and further to the same, the company is entering into a sale agreement for the acquisition of
land admeasuring to ~11,452.07 square metres, situated at Village Pune City (Bibvewadi), District Pune,
for a total consideration of ₹150 Crores. The requisite disclosures as per Regulation 30 of Listing
Regulations read with Circular dated January 30, 2026 (‘SEBI Circular’) is enclosed as Annexure-III.
The Board meeting commenced at 3:00 P.M. and was conclude at 3.43 P.M.
The aforementioned information will be available at the website of the Company at www.jupiterhospital.com
You are requested to kindly take the afore mentioned on record and oblige.
Thanking you,
For JUPITER LIFE LINE HOSPITALS LIMITED
Suma Upparatti
Company Secretary & Compliance Officer
Encl: As stated above
Annexure I
KKC & Associates LLP Aswin P. Malde & Co.
Chart€red Accountants Chartered Accountants
(formerly Khimji Kunverji & Co LLP)
Sunshine Tower, Level 19 405, Jay Commercial Plaza,
Senapati Bapat Marg Junction of S.L. Road & M.G, Road,
Elphinstone Road Mutund (W),
Mumbai-400 013 Mumbai- 400 080
Telephone: +91 22 5143 7333 Telephone: +91 22 6552 5689
lndependent Auditor's Review Report on unaudited standalone financial results for the quarter ended 30
September 2025 and year to date results for the period from 01 April 2026 to 30 September 2026 of Jupiter Life
Line Hospitals Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended.
The Board of Directors of
Jupiter Life Line Hospitals Limited
lntroduction
We have reviewed the accompanying statement of unaudited standatone financial results of Jupiter Life Line
Hospitals Limited ('the Company') for the quarter ended 30 September 2026 and year to date results for the
period from 0l April 2025 to 30 September2026 ('the Statement'), being submitted bythe Company pursuant
to the requirements of Regulation 33 of the Securities and Exchange Board of lndia (Listing Obligations and
Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations'). We have initiatled the
Statement for identification purpose only.
This Statement, which is the responsibility of the Company's Management and approved by the Board of
Directors ofthe Company, has been prepared in accordance with the recognition and measurement principles
laid down in the lndian Accounting Standard ('lnd AS') 34'lnterim Financial Reporting' specified in section
133 of the Companies Act, 2013 ('the Act'), read with relevant rules issued thereunder and other accounting
principtes generally accepted in lndia and in comptiance with Regulation 33 of the Listing Regulations. Our
responsibility is to express a conctusion on the Statement based on our review.
Scope of Review
We conducted our review ofthe Statement in accordance with the Standard on Review Engagements ('SRE')
2410 -'Review of lnterim Financiatlnformation Performed by the lndependent Auditor ofthe Entity'issued by
the lnstitute of Chartered Accountants of lndia ('the lCAl'). This standard requires that we plan and perform
the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A
review is limited primarilyto inquiries of company's personneLand analyticatprocedures apptied to financial
data and thus provides less assurance than an audit. We have not performed an audit and accordingty, we do
not express an audit opinion.
Conclusion
Based on our review conducted as above, nothing has come to our attention that causes us to believe that
the accompanying Statement, prepared in accordance with the recognition and measurement principles laid
down in lnd AS, specified under Section 133 of the Act as a mended, read with releva nt rules issued thereu nder
and other accounting principles generally accepted in lndia has not disctosed the information required to be
disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be
disclosed, or that it contains any materiat misstatement.
? MAT
F.R.N.
osSo
100725W
KKC & Associates ILP Aswin P. Malde & Co,
Chartered Accountants Chartered Accountants
(formerly Khimji Kunverji & Co LLP)
Sunshine Towet Level 19 405, Jay Commercial Plaza,
Senapati Bapat Marg Junction of S.L. Road & M.G, Road,
Etphinstone Road Mutund (W),
Mumbai-400 013 Mumbai- 400 080
Telephone: +91 22 6143 7333 Telephone: +91 22 6552 5589
Other Matter
The Standalone financiat results include the financiaI information of 1 (one) partnership firm whose financial
information being certified by the Management, reflects the Company's share of net loss after tax of Rs. 2.73
mitlion and Rs.5.97 million for the quarterended 30 September 2026 and forthe period from 0l April2026 to
30 September 2026 respectively, as considered in the Statement. According to the information and
explanations given to us by the Management, these fi na nciaI information are not material to the Company.
Ou r conclusion on the Statement is not modified in respect of the above matter.
For KKC & Associates LLP For Aswin P. Malde & Co
Chartered Accou ntants Chartered Accountants
(formerly Khimji Kunverji & Co LLP) Firm Registration Number: 100725W
Firm Registration Number: 105146W/W100621 VM-
ASSO F.R.N.
Hasmukh B Dedhia
Aswin P. Malde
10 $0725W
Pa rtn er Proprietor
lCAl Membership No: 033494 * lCAl Membership No: 032662
UDIN: 260349+tok H 6\1u 2?2 | UDIN: {6326g26tFf BNM t83o
Ptace: Mumbai Place: l\4umbai
Date: 23 October 2025 Date: 23 October 2025
JUPITER T!FE LINE HOSPITA6IIMITED
Resirrered Ofti.e:1004,loth floo Cr,' o3 t6 P0 o rD at€t ere O€ fficB !: ut Ein ane ett rc - ntl " tt x: ri pa : r5 evr sO l eiO t HM "" iu thi2 w00 at2 v"P ' "l TC p h1 a 3 nO7 e9 'o0 {ww8 k )'' l_ M8 as h M ara t& h vM t u _l 4u 0n od ( 6w 01)' Murnbai' Mahatashlla _400080
TelePhon. Nor022 62976630 EmaiI info@iuPiterhoePital'con w€brwww'jup te'hospital'com
STATEMENTOF UN AI,,DITEO STAN OALON E flNANCIAL iESULI! TOiTHEQUAAIER ANO HAIT YEAi ENOEO SEPTEMBER 30' 2025
tratf vsEnaea Ended
lo26 -
-Yeai
1. Revenue nom oP€rations 1,6 64 85 .. 99 27 3,2 18 04 6. .8 45 3 3,1 15 18 3. .1 06 9 6,9 13 70 5. 18 52 5,9 23 48 1. .0 43 5 t7,9 47 26 2.2 .54 t
3,774.89 3,391.28 3,271.25 1,106,17 6,179.48 12,:t98.7s
cP hu .. n(h ga es re 5 i n o inl vm ee nd tr oc ra il e !c o on f t mum eda ltb ale l t c, od nr tu uE m .a bn led s t ,u drg ruc Sa !l an ne dm! 51 14 7. .8 13 4 588 7 .39 53 55 (9 s. .3 24 s) 7,20 23 4. .7 76 0 1.o1 {0 8. .5 97 8) 2 (, 12 03 16 .. 4r8 0)
Emrloyee benef t exPente 6 82 77 3. .8 15 5 85 06 4t. .5 04 6 4 88 34 3- .65 14 1 1, ,1 69 77 7. .3 29 2 !,49 t5 78 .. 64 93 2 2, ,0 85 66 {.. 939 9
90.42 81.16 29.63 171.58 59.64 r28.15
Oepre.ialion and amorlitation e
[Showing first 8,000 characters — download PDF for full document]